# An Observational Study on the Safety and Efficacy of Henagliflozin in Chinese Patients With Type 2 Diabetes

> **NCT06959030** · — · RECRUITING · sponsor: **Second Affiliated Hospital of Guangxi Medical University** · enrollment: 10000 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus (T2DM)

## Interventions

- **OTHER:** No Intervention: Observational Cohort

## Key facts

- **NCT ID:** NCT06959030
- **Lead sponsor:** Second Affiliated Hospital of Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-19
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06959030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06959030, "An Observational Study on the Safety and Efficacy of Henagliflozin in Chinese Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06959030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*